GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 196 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2018. The put-call ratio across all filers is 0.35 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $701,000 | +223.0% | 10,300 | +51.2% | 0.05% | +165.0% |
| Q2 2022 | $217,000 | +261.7% | 6,810 | +290.0% | 0.02% | +300.0% |
| Q1 2022 | $60,000 | -6.2% | 1,746 | -20.6% | 0.01% | 0.0% |
| Q4 2021 | $64,000 | +255.6% | 2,200 | +514.5% | 0.01% | -58.3% |
| Q1 2020 | $18,000 | -61.7% | 358 | -60.2% | 0.01% | +140.0% |
| Q2 2019 | $47,000 | -33.8% | 900 | -52.4% | 0.01% | 0.0% |
| Q3 2018 | $71,000 | -15.5% | 1,890 | +1.1% | 0.01% | -16.7% |
| Q2 2018 | $84,000 | +236.0% | 1,869 | +251.3% | 0.01% | +200.0% |
| Q1 2018 | $25,000 | -73.4% | 532 | -77.8% | 0.00% | -77.8% |
| Q4 2017 | $94,000 | +422.2% | 2,394 | +295.0% | 0.01% | +350.0% |
| Q3 2017 | $18,000 | -48.6% | 606 | -53.3% | 0.00% | -33.3% |
| Q2 2017 | $35,000 | -74.1% | 1,298 | -64.6% | 0.00% | -78.6% |
| Q1 2017 | $135,000 | +145.5% | 3,664 | -5.3% | 0.01% | +133.3% |
| Q4 2016 | $55,000 | +71.9% | 3,870 | +173.7% | 0.01% | +50.0% |
| Q3 2016 | $32,000 | – | 1,414 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fernwood Investment Management, LLC | 383,702 | $14,581,000 | 7.71% |
| Perceptive Advisors | 5,148,910 | $195,658,000 | 5.23% |
| Grace Capital | 312,514 | $11,876,000 | 4.65% |
| NEXTHERA CAPITAL LP | 549,231 | $20,871,000 | 4.00% |
| Asymmetry Capital Management, L.P. | 103,449 | $3,931,000 | 3.63% |
| Camber Capital Management LP | 2,075,000 | $78,850,000 | 3.37% |
| Casdin Capital, LLC | 440,000 | $16,720,000 | 2.03% |
| EMORY UNIVERSITY | 53,951 | $2,050,000 | 1.34% |
| ArchPoint Investors | 129,435 | $4,919,000 | 1.34% |
| Ghost Tree Capital, LLC | 150,000 | $5,700,000 | 1.21% |